(Q41171838)

27 September 2017

1 reference

title

Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics (English)

1 reference

27 September 2017

1 reference

M R Weir

1

1 reference

27 September 2017

J M Flack

series ordinal

2

1 reference

27 September 2017

W B Applegate

series ordinal

3

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

American Journal of Medicine

27 September 2017

published in

1 reference

27 September 2017

volume

101

1 reference

27 September 2017

issue

3A

1 reference

27 September 2017

page(s)

83S-92S

1 reference

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

The effect of low-dose hydrochlorothiazide on blood pressure, serum potassium, and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Antihypertensive effects of low doses of hydrochlorothiazide in hypertensive black Zimbabweans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Short report: ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. The East Germany Collaborative Trial Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

The effect of different diuretics on elevated blood pressure and serum potassium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Prevention of the Glucose Intolerance of Thiazide Diuretics by Maintenance of Body Potassium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Effects of antihypertensive therapy on serum lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. The MRFIT Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Glucose and cholesterol elevations during thiazide therapy: Intention-to-treat versus actual on-therapy experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Increase in serum-lipids during treatment of hypertension with chlorthalidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Low dose loop diuretics in essential hypertension. Experience with torasemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

The effects of antihypertensive therapy on the quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

The Framingham Disability Study: II. Physical disability among the aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

The assessment of social networks and social support in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Systolic Hypertension of the Elderly Program (SHEP). Part 9: Behavioral characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

A Guttman health scale for the aged

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Effect of antihypertensives on sexual function and quality of life: the TAIM Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Future goals for the treatment of hypertension in the elderly with reference to STOP-Hypertension, SHEP, and the MRC trial in older adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

The treatment of elderly hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Comparative efficacy of diuretics: benefit versus risk: results of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900271-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(96)00271-9

1 reference

27 September 2017

1 reference